SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    Fatma E. Mohamed, Rajai M. Al-Jehani, Shane S. Minogue, Fausto Andreola, Alison Winstanley, Steven W.M. Olde Damink, Abeba Habtesion, Massimo Malagó, Nathan Davies, Tu Vinh Luong, Amar P. Dhillon, Rajeshwar P. Mookerjee, Dipok K. Dhar, Rajiv Jalan, Effect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma, Liver International, 2015, 35, 2
  2. 2
    Vignan Manne, Ehsaan Akhtar, Sammy Saab, Cirrhosis Regression in Patients With Viral Hepatitis B and C, Journal of Clinical Gastroenterology, 2014, 48, 9, e76

    CrossRef

  3. 3
    Chao-Ming Hung, Wei-Chien Huang, Hsiao-Lin Pan, Pei-Hsuan Chien, Chih-Wen Lin, Lei-Chin Chen, Yu-Fong Chien, Ching-Chiao Lin, Kar-Hee Leow, Wen-Shu Chen, Jhen-Yu Chen, Chien-Yi Ho, Pao-Sheng Hou, Yun-Ju Chen, Hepatitis B Virus X Upregulates HuR Protein Level to Stabilize HER2 Expression in Hepatocellular Carcinoma Cells, BioMed Research International, 2014, 2014, 1

    CrossRef

  4. 4
    Jin Ding, Hongyang Wang, Multiple interactive factors in hepatocarcinogenesis, Cancer Letters, 2014, 346, 1, 17

    CrossRef

  5. 5
    Mi Sung Park, Kwang-Hyub Han, Seung Up Kim, Non-invasive prediction of development of hepatocellular carcinoma using transient elastography in patients with chronic liver disease, Expert Review of Gastroenterology & Hepatology, 2014, 8, 5, 501

    CrossRef

  6. 6
    Raxitkumar Jinjuvadia, Suthat Liangpunsakul, Fadi Antaki, Past Exposure to Hepatitis B, Journal of Clinical Gastroenterology, 2014, 48, 3, 267

    CrossRef

  7. 7
    Michael C. Kew, The Role of Cirrhosis in the Etiology of Hepatocellular Carcinoma, Journal of Gastrointestinal Cancer, 2014, 45, 1, 12

    CrossRef

  8. 8
    Eiichi Ogawa, Norihiro Furusyo, Eiji Kajiwara, Kazuhiro Takahashi, Hideyuki Nomura, Toshihiro Maruyama, Yuichi Tanabe, Takeaki Satoh, Makoto Nakamuta, Kazuhiro Kotoh, Koichi Azuma, Kazufumi Dohmen, Shinji Shimoda, Jun Hayashi, Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: A prospective, multicenter study, Journal of Hepatology, 2013, 58, 3, 495

    CrossRef

  9. 9
    M. A. BALOGUN, J. V. PARRY, K. MUTTON, C. OKOLO, L. BENONS, H. BAXENDALE, T. HARDIMAN, E. H. BOXALL, J. SIRA, M. BROWN, S. BARNETT, U. GUNGABISSOON, A. WILLIAMS, D. A. KELLY, S. VIJERATNAM, S. IJAZ, B. TAYLOR, C. G. TEO, M. E. RAMSAY, Hepatitis B virus transmission in pre-adolescent schoolchildren in four multi-ethnic areas of England, Epidemiology and Infection, 2013, 141, 05, 916

    CrossRef

  10. 10
    Yun-Ju Chen, Pei-Hsuan Chien, Wen-Shu Chen, Yu-Fong Chien, Ya-Ying Hsu, Li-Yun Wang, Jhen-Yu Chen, Chih-Wen Lin, Tzung-Chi Huang, Yung-Luen Yu, Wei-Chien Huang, Hepatitis B Virus-Encoded X Protein Downregulates EGFR Expression via Inducing MicroRNA-7 in Hepatocellular Carcinoma Cells, Evidence-Based Complementary and Alternative Medicine, 2013, 2013, 1

    CrossRef

  11. 11
    Mi Na Kim, Beom Kyung Kim, Kwang-Hyub Han, Hepatocellular carcinoma in patients with chronic hepatitis C virus infection in the Asia–Pacific region, Journal of Gastroenterology, 2013, 48, 6, 681

    CrossRef

  12. 12
    Frédéric Morinet, Luana Casetti, Jean-Hugues François, Claude Capron, Sylvie Pillet, Oxygen tension level and human viral infections, Virology, 2013, 444, 1-2, 31

    CrossRef

  13. 13
    Mihael Vucur, Florian Reisinger, Jérémie Gautheron, Joern Janssen, Christoph Roderburg, David Vargas Cardenas, Karina Kreggenwinkel, Christiane Koppe, Linda Hammerich, Razq Hakem, Kristian Unger, Achim Weber, Nikolaus Gassler, Mark Luedde, Norbert Frey, Ulf Peter Neumann, Frank Tacke, Christian Trautwein, Mathias Heikenwalder, Tom Luedde, RIP3 Inhibits Inflammatory Hepatocarcinogenesis but Promotes Cholestasis by Controlling Caspase-8- and JNK-Dependent Compensatory Cell Proliferation, Cell Reports, 2013, 4, 4, 776

    CrossRef

  14. 14
    Song Fang, Shi-feng Huang, Ju Cao, Yang-an Wen, Li-Ping Zhang, Guo-Sheng Ren, Silencing of PCDH10 in hepatocellular carcinoma via de novo DNA methylation independent of HBV infection or HBX expression, Clinical and Experimental Medicine, 2013, 13, 2, 127

    CrossRef

  15. 15
    Mausumi Bharadwaj, Gaurav Roy, Koushik Dutta, Mohammad Misbah, Mohammad Husain, Showket Hussain, Tackling hepatitis B virus-associated hepatocellular carcinoma—the future is now, Cancer and Metastasis Reviews, 2013, 32, 1-2, 229

    CrossRef

  16. 16
    Eun Sun Jang, Sook-Hyang Jeong, Sang Hyub Lee, Sung Ho Hwang, So Yeon Ahn, Jaebong Lee, Young Soo Park, Jin Hyoek Hwang, Jin-Wook Kim, Nayoung Kim, Dong Ho Lee, Hyun Young Kim, The effect of coffee consumption on the development of hepatocellular carcinoma in hepatitis B virus endemic area, Liver International, 2013, 33, 7
  17. 17
    Inken Wierstra, 2013,

    CrossRef

  18. 18
    Sun Young Lee, Kwang Hoon Song, Imhoi Koo, Kee-Ho Lee, Kyung-Suk Suh, Bu-Yeo Kim, Comparison of pathways associated with hepatitis B- and C-infected hepatocellular carcinoma using pathway-based class discrimination method, Genomics, 2012, 99, 6, 347

    CrossRef

  19. 19
    Jau-Jiuan Sheu, Joseph J. Keller, Herng-Ching Lin, Increased risk of cancer after Bell’s palsy: a 5-year follow-up study, Journal of Neuro-Oncology, 2012, 110, 2, 215

    CrossRef

  20. 20
    Jayashree Bagchi Chakraborty, Fiona Oakley, Meagan J. Walsh, Mechanisms and Biomarkers of Apoptosis in Liver Disease and Fibrosis, International Journal of Hepatology, 2012, 2012, 1

    CrossRef

  21. 21
    Matthias Bartneck, Thomas Ritz, Heidrun A. Keul, Mona Wambach, Jörg Bornemann, Uwe Gbureck, Josef Ehling, Twan Lammers, Felix Heymann, Nikolaus Gassler, Tom Lüdde, Christian Trautwein, Jürgen Groll, Frank Tacke, Peptide-Functionalized Gold Nanorods Increase Liver Injury in Hepatitis, ACS Nano, 2012, 6, 10, 8767

    CrossRef

  22. 22
    Zhenhui Xin, Wei Zhang, Aiqiang Xu, Li Zhang, Tao Yan, Zhuo Li, Xiaopan Wu, Xilin Zhu, Juan Ma, Ke Li, Hui Li, Ying Liu, Polymorphisms in the potential functional regions of the TGF-β 1 and TGF-β receptor genes and disease susceptibility in HBV-related hepatocellular carcinoma patients, Molecular Carcinogenesis, 2012, 51, S1
  23. 23
    Sandra Bühler, Ralf Bartenschlager, Promotion of Hepatocellular Carcinoma by Hepatitis C Virus, Digestive Diseases, 2012, 30, 5, 445

    CrossRef

  24. 24
    Romina S Goldszmid, Giorgio Trinchieri, The price of immunity, Nature Immunology, 2012, 13, 10, 932

    CrossRef

  25. 25
    Ghulam Mujtaba, Shah Jahan, Saba Khaliq, Nasir Mahmood, Fouzia Javed, Nakhshab Choudhry, Ayaz Aslam, Tariq Bashir, Mariam Faiz, Current Status of Transmission Risk Factors and Genotypes of Hepatitis C Virus, In Punjabi Population of Pakistan, International Journal for Agro Veterinary and Medical Sciences, 2011, 271

    CrossRef

  26. 26
    Ishtiaq Qadri, Kaneez Fatima, Hany AbdeL-Hafiz, Hepatitis B virus X protein impedes the DNA repair via its association with transcription factor, TFIIH, BMC Microbiology, 2011, 11, 1, 48

    CrossRef

  27. 27
    John A. Harvin, George Van Buren, KuoJen Tsao, Putao Cen, Tien C. Ko, Curtis J. Wray, Hepatocellular Carcinoma Survival in Uninsured and Underinsured Patients, Journal of Surgical Research, 2011, 166, 2, 189

    CrossRef

  28. 28
    Kengo Yoshida, Waka Ohishi, Eiji Nakashima, Saeko Fujiwara, Masazumi Akahoshi, Fumiyoshi Kasagi, Kazuaki Chayama, Masayuki Hakoda, Seishi Kyoizumi, Kei Nakachi, Tomonori Hayashi, Yoichiro Kusunoki, Lymphocyte subset characterization associated with persistent hepatitis C virus infection and subsequent progression of liver fibrosis, Human Immunology, 2011, 72, 10, 821

    CrossRef

  29. 29
    J. Fung, C.-L. Lai, W.-K. Seto, M.-F. Yuen, Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B, Journal of Antimicrobial Chemotherapy, 2011, 66, 12, 2715

    CrossRef

  30. 30
    Danny Ka Ho Wong, Fung Yu Huang, Ching Lung Lai, Ronnie Tung Ping Poon, Wai Kay Seto, James Fung, Ivan Fan Ngai Hung, Man Fung Yuen, Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma, Hepatology, 2011, 54, 3
  31. 31
    J. Fung, C.-L. Lai, W.-K. Seto, D. K.-H. Wong, M.-F. Yuen, Prognostic significance of liver stiffness for hepatocellular carcinoma and mortality in HBeAg-negative chronic hepatitis B, Journal of Viral Hepatitis, 2011, 18, 10
  32. 32
    Kyu Sik Jung, Seung Up Kim, Sang Hoon Ahn, Young Nyun Park, Do Young Kim, Jun Yong Park, Chae Yoon Chon, Eun Hee Choi, Kwang-Hyub Han, Risk assessment of hepatitis B virus–related hepatocellular carcinoma development using liver stiffness measurement (FibroScan), Hepatology, 2011, 53, 3
  33. 33
    Chun-che Lin, Wen-hu Liu, Zhi-hong Wang, Mei-chin Yin, Vitamins B status and antioxidative defense in patients with chronic hepatitis B or hepatitis C virus infection, European Journal of Nutrition, 2011, 50, 7, 499

    CrossRef

  34. 34
    Christine Kaefer, John Milner, Herbal Medicine, 2011,

    CrossRef

  35. 35
    Gakuhei Son, Michael Kremer, Ian N. Hines, Contribution of Gut Bacteria to Liver Pathobiology, Gastroenterology Research and Practice, 2010, 2010, 1

    CrossRef

  36. 36
    James Fung, Ching-Lung Lai, Man-Fung Yuen, Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B, Expert Review of Anti-infective Therapy, 2010, 8, 6, 717

    CrossRef

  37. 37
    Melissa Kennedy, Sophoclis P Alexopoulos, Hepatitis B virus infection and liver transplantation, Current Opinion in Organ Transplantation, 2010, 15, 3, 310

    CrossRef

  38. You have full text access to this Open Access content38
    Ying-Bing Deng, Genta Nagae, Yutaka Midorikawa, Koichi Yagi, Shuichi Tsutsumi, Shogo Yamamoto, Kiyoshi Hasegawa, Norihiro Kokudo, Hiroyuki Aburatani, Atsushi Kaneda, Identification of genes preferentially methylated in hepatitis C virus-related hepatocellular carcinoma, Cancer Science, 2010, 101, 6
  39. 39
    H. Conroy, L. Mawhinney, S. C. Donnelly, Inflammation and cancer: macrophage migration inhibitory factor (MIF)--the potential missing link, QJM, 2010, 103, 11, 831

    CrossRef

  40. 40
    A. K. Singal, D. H. Freeman Jr, B. S. Anand, Meta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinoma, Alimentary Pharmacology & Therapeutics, 2010, 32, 7
  41. 41
    Thiago de Almeida Pereira, Rafal P Witek, Wing-Kin Syn, Steve S Choi, Shelton Bradrick, Gamze F Karaca, Kolade M Agboola, Youngmi Jung, Alessia Omenetti, Cynthia A Moylan, Liu Yang, Martin E Fernandez-Zapico, Ravi Jhaveri, Vijay H Shah, Fausto E Pereira, Anna M Diehl, Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinoma, Laboratory Investigation, 2010, 90, 12, 1690

    CrossRef

  42. 42
    Wai-Kay Seto, Ching-Lung Lai, Man-Fung Yuen, Hepatitis Viruses and Hepatocellular Carcinoma,